相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract
Remond J. A. Fijneman et al.
CANCER SCIENCE (2012)
Opposing Effects of Runx2 and Estradiol on Breast Cancer Cell Proliferation: In Vitro Identification of Reciprocally Regulated Gene Signature Related to Clinical Letrozole Responsiveness
Nyam-Osor Chimge et al.
CLINICAL CANCER RESEARCH (2012)
RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis
Kentson Lam et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts
Jurjen J. Boonstra et al.
GENES CHROMOSOMES & CANCER (2012)
Genomic Promoter Occupancy of Runt-related Transcription Factor RUNX2 in Osteosarcoma Cells Identifies Genes Involved in Cell Adhesion and Motility
Margaretha van der Deen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer
Chunri Yan et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion
Gillian H. Little et al.
NUCLEIC ACIDS RESEARCH (2012)
RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor alpha
B. Huang et al.
ONCOGENE (2012)
Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells
S. K. Baniwal et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancer
Shu-Pin Huang et al.
BJU INTERNATIONAL (2011)
Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models
Niv Pencovich et al.
BLOOD (2011)
Metastatic bone disease: Role of transcription factors and future targets
Jitesh Pratap et al.
BONE (2011)
Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and risk of colon and rectal cancer: additional support for a TGF-β-signaling pathway
Martha L. Slattery et al.
CARCINOGENESIS (2011)
RUNX1 and its understudied role in breast cancer
Kevin A. Janes
CELL CYCLE (2011)
Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma
Jesus Planaguma et al.
HUMAN PATHOLOGY (2011)
Lung Tumor-associated Osteoblast-derived Bone Morphogenetic Protein-2 Increased Epithelial-to-Mesenchymal Transition of Cancer by Runx2/Snail Signaling Pathway
Ya-Ling Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Loss of Runt-Related Transcription Factor 3 Causes Development and Progression of Hepatocellular Carcinoma
Hidenori Shiraha et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Inducible Expression of Runx2 Results in Multiorgan Abnormalities in Mice
Nan He et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
Verena I. Gaidzik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations
Chen Wu et al.
NATURE GENETICS (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression
Lixin Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Promoter CpG island hypermethylation during breast cancer progression
So Yeon Park et al.
VIRCHOWS ARCHIV (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBF beta-dependent expression of the Wnt antagonist, sclerostin
Daniel Mendoza-Villanueva et al.
BREAST CANCER RESEARCH (2011)
Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2
Nyam-Osor Chimge et al.
BREAST CANCER RESEARCH (2011)
Estrogen Receptor α Controls a Gene Network in Luminal-Like Breast Cancer Cells Comprising Multiple Transcription Factors and MicroRNAs
Luigi Cicatiello et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Runx2 in normal tissues and cancer cells: A developing story
Karen Blyth et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Runx2 in human breast carcinoma: its potential roles in cancer progression
Yoshiaki Onodera et al.
CANCER SCIENCE (2010)
Regulation of bone development and extracellular matrix protein genes by RUNX2
Toshihisa Komori
CELL AND TISSUE RESEARCH (2010)
Regulation of Adult Bone Turnover by Sex Steroids
Baruch Frenkel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
Alexander Kohlmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Genome-Wide Analysis of Estrogen Receptor α DNA Binding and Tethering Mechanisms Identifies Runx1 as a Novel Tethering Factor in Receptor-Mediated Transcriptional Activation
Joshua D. Stender et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Runx1 Directly Promotes Proliferation of Hair Follicle Stem Cells and Epithelial Tumor Formation in Mouse Skin
Charlene S. L. Hoi et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Runx2 regulates survivin expression in prostate cancer cells
Minyoung Lim et al.
LABORATORY INVESTIGATION (2010)
The Runx transcriptional co-activator, CBFβ, is essential for invasion of breast cancer cells
Daniel Mendoza-Villanueva et al.
MOLECULAR CANCER (2010)
Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis
Sanjeev K. Baniwal et al.
MOLECULAR CANCER (2010)
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML
F. Dicker et al.
LEUKEMIA (2010)
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
J. Akech et al.
ONCOGENE (2010)
ERα signaling through slug regulates E-cadherin and EMT
Y. Ye et al.
ONCOGENE (2010)
RUNX3 is multifunctional in carcinogenesis of multiple solid tumors
L. S. H. Chuang et al.
ONCOGENE (2010)
Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines
Mitsutaka Kadota et al.
PLOS ONE (2010)
Bone Morphogenetic Protein 7 Is Expressed in Prostate Cancer Metastases and Its Effects on Prostate Tumor Cells Depend on Cell Phenotype and the Tumor Microenvironment
Colm Morrissey et al.
NEOPLASIA (2010)
Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility
David T. Leong et al.
BREAST CANCER RESEARCH (2010)
RUNX3 Inactivation in Colorectal Polyps Arising Through Different Pathways of Colonic Carcinogenesis
Manish M. Subramaniam et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Runx2 induces acute myeloid leukemia in cooperation with Cbfβ-SMMHC in mice
Ya-Huei Kuo et al.
BLOOD (2009)
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations
Jih-Luh Tang et al.
BLOOD (2009)
Runx1 promotes B-cell survival and lymphoma development
Karen Blyth et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression
Manish Mani Subramaniam et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
R. Soong et al.
BRITISH JOURNAL OF CANCER (2009)
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
Xiang H. -F. Zhang et al.
CANCER CELL (2009)
BMP7 influences proliferation, migration, and invasion of breast cancer cells
Emma-Leena Alarmo et al.
CANCER LETTERS (2009)
Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer Progression
Jitesh Pratap et al.
CANCER RESEARCH (2009)
Identification of PDE4D as a Proliferation Promoting Factor in Prostate Cancer Using a Sleeping Beauty Transposon-Based Somatic Mutagenesis Screen
Eric P. Rahrmann et al.
CANCER RESEARCH (2009)
Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer
Kakoli Das et al.
EUROPEAN JOURNAL OF CANCER (2009)
RUNX3 protein is overexpressed in human epithelial ovarian cancer
Nicole S. Nevadunsky et al.
GYNECOLOGIC ONCOLOGY (2009)
An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasis
Andreas Doll et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor-Positive, Aromatase Inhibitor-Resistant Advanced Breast Cancer A Phase 2 Randomized Study
Matthew J. Ellis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas
Feng Gao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Promoter Methylation in APC, RUNX3, and GSTP1 and Mortality in Prostate Cancer Patients
Lorenzo Richiardi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Downregulation of RUNX1 by RUNX3 Requires the RUNX3 VWRPY Sequence and Is Essential for Epstein-Barr Virus-Driven B-Cell Proliferation
Gareth Brady et al.
JOURNAL OF VIROLOGY (2009)
Repression of Runx2 by Androgen Receptor (AR) in Osteoblasts and Prostate Cancer Cells: AR Binds Runx2 and Abrogates Its Recruitment to DNA
Sanjeev K. Baniwal et al.
MOLECULAR ENDOCRINOLOGY (2009)
RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation
M-C Kuo et al.
LEUKEMIA (2009)
RUNX3 Has an Oncogenic Role in Head and Neck Cancer
Takaaki Tsunematsu et al.
PLOS ONE (2009)
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
Ina Radtke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes
Veronique Gelsi-Boyer et al.
BMC CANCER (2008)
RUNX3 attenuates β-catenin/T cell factors in intestinal tumorigenesis
Kosei Ito et al.
CANCER CELL (2008)
RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22):: case report and review of the literature
Etienne De Braekeleer et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells
Jitesh Pratap et al.
CANCER RESEARCH (2008)
RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking
Erika M. Wolff et al.
CANCER RESEARCH (2008)
The quest for the 1p36 tumor suppressor
Anindya Bagchi et al.
CANCER RESEARCH (2008)
Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome
Alfred S. L. Cheng et al.
CANCER RESEARCH (2008)
Modulation of Runx2 Activity by Estrogen Receptor-α: Implications for Osteoporosis and Breast Cancer
Omar Khalid et al.
ENDOCRINOLOGY (2008)
Unliganded estrogen receptor α inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21WAF1)
Marie Maynadier et al.
FASEB JOURNAL (2008)
Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells
Toyoshi Endo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
Terje Ahlquist et al.
MOLECULAR CANCER (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival
S. Wotton et al.
ONCOGENE (2008)
Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines
Ying Jiang et al.
PATHOBIOLOGY (2008)
Opinion - Survivin, cancer networks and pathway-directed drug discovery
Dario C. Altieri
NATURE REVIEWS CANCER (2008)
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer
H. Kayed et al.
BRITISH JOURNAL OF CANCER (2007)
Downregulation of the RUNX3 gene by promoter hypermethylation and hemizygous deletion in breast cancer
Ki-Tae Hwang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Runx2 determines bone maturity and turnover rate in postnatal bone loss in estrogen deficiency
Zenjiro Maruyama et al.
DEVELOPMENTAL DYNAMICS (2007)
RUNX1-RUNX1 homodimerization modulates RUNX1 activity and function
Donglan Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment
Cornelius Miething et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer
Efthimia Tsoli et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion
Vasily Vasko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Downregulation of RUNX3 and TES by hypermethylation in glioblastoma
W. Mueller et al.
ONCOGENE (2007)
Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2
Daniel W. Young et al.
NATURE (2007)
RUNX3 protein is overexpressed in human basal cell carcinomas
M. Salto-Tellez et al.
ONCOGENE (2006)
Candidate regulstors of mammary branching morphogenesis identified by genome-wide transcript analysis
Hosein Kouros-Mehr et al.
DEVELOPMENTAL DYNAMICS (2006)
Clinical features of metastatic bone disease and risk of skeletal morbidity
Robert E. Coleman
CLINICAL CANCER RESEARCH (2006)
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation
Gaoping Chen et al.
CANCER (2006)
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer
Quek Choon Lau et al.
CANCER RESEARCH (2006)
Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables
SS Cross et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both smad and c-jun NH2-terminal kinase pathways
SX Yang et al.
CANCER RESEARCH (2006)
Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo
K Blyth et al.
CANCER RESEARCH (2006)
Regulatory mechanisms controlling human E-cadherin gene expression
YN Liu et al.
ONCOGENE (2005)
DNA methylation-associated inactivation of TGFβ-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers
M Suzuki et al.
BRITISH JOURNAL OF CANCER (2005)
A role for Runx2 in normal mammary gland and breast cancer bone metastasis
P Shore
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors
WJ Kim et al.
CANCER RESEARCH (2005)
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion
J Pratap et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system
AJ Dupuy et al.
NATURE (2005)
The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts
M Galindo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The RUNX genes: Gain or loss of function in cancer
K Blyth et al.
NATURE REVIEWS CANCER (2005)
Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal development
N Smith et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells
LC Spender et al.
ONCOGENE (2005)
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo
A Javed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer
C Sakakura et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia
DP Steensma et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Mechanisms of disease: Mechanisms of bone metastasis
GD Roodman
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma
TY Kim et al.
LABORATORY INVESTIGATION (2004)
Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines
M Wada et al.
ONCOGENE (2004)
High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia
H Harada et al.
BLOOD (2004)
A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma
J Planagumà et al.
CANCER RESEARCH (2004)
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma
DM Thomas et al.
JOURNAL OF CELL BIOLOGY (2004)
Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease
GL Barnes et al.
CANCER RESEARCH (2004)
Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma
Y Oshimo et al.
PATHOBIOLOGY (2004)
Growth regulation of gastric epithelial cells by Runx3
H Fukamachi et al.
ONCOGENE (2004)
Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma
CC Lau et al.
GENES CHROMOSOMES & CANCER (2004)
The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression
CK Inman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A fluorescence in situ hybridization study of TEL-AML1 fusion gene in B-cell acute lymphoblastic leukemia (1984-2001)
N Douet-Guilbert et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function
KD Brubaker et al.
PROSTATE (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Estrogen receptors and distinct patterns of breast cancer relapse
KR Hess et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia:: a study of 20 cases
L Harewood et al.
LEUKEMIA (2003)
The Runx genes as dominant oncogenes
ER Cameron et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
Identification of RUNX1/AML1 as a classical tumor suppressor gene
FPG Silva et al.
ONCOGENE (2003)
Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia
H Harada et al.
BLOOD (2003)
A molecular signature of metastasis in primary solid tumors
S Ramaswamy et al.
NATURE GENETICS (2003)
Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome
HM Robinson et al.
LEUKEMIA (2003)
Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma
G Carlinfante et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
New genes involved in cancer identified by retroviral tagging
T Suzuki et al.
NATURE GENETICS (2002)
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
H Mikkers et al.
NATURE GENETICS (2002)
High bone resorption in adult aging Transgenic mice overexpressing Cbfa1/Runx2 in cells of the osteoblastic lineage
V Geoffroy et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons
D Levanon et al.
EMBO JOURNAL (2002)
The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene
M Stewart et al.
JOURNAL OF VIROLOGY (2002)
Causal relationship between the loss of RUNX3 expression and gastric cancer
QL Li et al.
CELL (2002)
In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis
J Michaud et al.
BLOOD (2002)
Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures
WG Liu et al.
JOURNAL OF CELL BIOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms
N Platet et al.
MOLECULAR ENDOCRINOLOGY (2000)
分享论文
